Your browser doesn't support javascript.
loading
Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD.
Poe, Jonathan C; Fang, Jiyuan; Zhang, Dadong; Lee, Marissa R; DiCioccio, Rachel A; Su, Hsuan; Qin, Xiaodi; Zhang, Jennifer Y; Visentin, Jonathan; Bracken, Sonali J; Ho, Vincent T; Wang, Kathy S; Rose, Jeremy J; Pavletic, Steven Z; Hakim, Frances T; Jia, Wei; Suthers, Amy N; Curry-Chisolm, Itaevia M; Horwitz, Mitchell E; Rizzieri, David A; McManigle, William C; Chao, Nelson J; Cardones, Adela R; Xie, Jichun; Owzar, Kouros; Sarantopoulos, Stefanie.
Afiliación
  • Poe JC; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.
  • Fang J; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.
  • Zhang D; Duke Cancer Institute, Durham, North Carolina, USA.
  • Lee MR; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.
  • DiCioccio RA; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.
  • Su H; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.
  • Qin X; Duke Cancer Institute, Durham, North Carolina, USA.
  • Zhang JY; Department of Dermatology, Duke University Medical Center, Durham, North Carolina, USA.
  • Visentin J; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.
  • Bracken SJ; Department of Immunology and Immunogenetics, Bordeaux University Hospital, Bordeaux, France.
  • Ho VT; UMR CNRS 5164 ImmunoConcEpT, Bordeaux University, Bordeaux, France.
  • Wang KS; Department of Medicine, Division of Rheumatology and Immunology, Duke University Medical Center, Durham, North Carolina, USA.
  • Rose JJ; Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Pavletic SZ; Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Hakim FT; Experimental Transplantation and Immunology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA.
  • Jia W; Experimental Transplantation and Immunology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA.
  • Suthers AN; Experimental Transplantation and Immunology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA.
  • Curry-Chisolm IM; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.
  • Horwitz ME; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.
  • Rizzieri DA; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.
  • McManigle WC; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.
  • Chao NJ; Duke Cancer Institute, Durham, North Carolina, USA.
  • Cardones AR; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.
  • Xie J; Duke Cancer Institute, Durham, North Carolina, USA.
  • Owzar K; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.
  • Sarantopoulos S; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.
JCI Insight ; 8(11)2023 06 08.
Article en En | MEDLINE | ID: mdl-37129971

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Síndrome de Bronquiolitis Obliterante / Enfermedad Injerto contra Huésped Límite: Humans Idioma: En Revista: JCI Insight Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Síndrome de Bronquiolitis Obliterante / Enfermedad Injerto contra Huésped Límite: Humans Idioma: En Revista: JCI Insight Año: 2023 Tipo del documento: Article
...